« Return to News | Awards & Advancement

Accelovance names Boccia oncology medical director

Friday, March 1, 2013 02:45 PM

Accelovance has named Dr. Ralph Boccia, M.D., FACP, oncology medical director.  The Rockville, Md.-based CRO caters to biotech and small/mid-sized pharma sponsors.

Dr. Boccia is a founder and medical director of the Center for Cancer and Blood Disorders.  He also is an active clinical associate professor of medicine at Georgetown University and consulting medical director of the International Oncology Network (ION) Clinical Research Program.

"We are thrilled to have a recognized leader in medical oncology and hematology, Dr. Ralph V. Boccia, join our organization.  His 31 years of practice and clinical research are an asset to the clients we serve as we help define patient populations, study protocols and program approaches," said Stephen J. Trevisan, Accelovance president and CEO.

Dr. Boccia is a board-certified medical oncologist with specialties in internal medicine and hematology. 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.